Cambridge Investment Research Advisors’s Sigilon Therapeutics, Inc. Common Stock SGTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-845	Closed	-$16K	–	3260
2022 Q1	$16K	Buy	+845	New	+$16K	﹤0.01%	3128